Institute of Oncology Ljubljana
🇸🇮Slovenia
Induction Chemotherapy,Radiochemotherapy, Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer
Phase 2
- Conditions
- Rectal Cancer
- First Posted Date
- 2011-12-09
- Last Posted Date
- 2011-12-09
- Lead Sponsor
- Institute of Oncology Ljubljana
- Target Recruit Count
- 60
- Registration Number
- NCT01489332
- Locations
- 🇸🇮
Institute of Oncology, Ljubljana, Slovenia
Treatment Selection According to Skin Reaction to Cetuximab
Phase 2
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2011-11-16
- Last Posted Date
- 2011-12-13
- Lead Sponsor
- Institute of Oncology Ljubljana
- Target Recruit Count
- 120
- Registration Number
- NCT01472653
- Locations
- 🇸🇮
Institute of Oncology Ljubljana, Ljubljana, Slovenia
Cisplatin With Alimta or Gemcitabine in Long Infusion for Mesothelioma
Phase 2
- Conditions
- Mesothelioma
- Interventions
- Procedure: Gemcitabine in long infusion
- First Posted Date
- 2011-01-24
- Last Posted Date
- 2011-01-24
- Lead Sponsor
- Institute of Oncology Ljubljana
- Target Recruit Count
- 72
- Registration Number
- NCT01281800
- Locations
- 🇸🇮
Institute of Oncology Ljubljana, Ljubljana, Slovenia
Health-related Quality of Life in General Slovenian Population
- Conditions
- Health-related Quality of Life
- First Posted Date
- 2011-01-04
- Last Posted Date
- 2012-03-26
- Lead Sponsor
- Institute of Oncology Ljubljana
- Target Recruit Count
- 600
- Registration Number
- NCT01269489
- Locations
- 🇸🇮
Institute of Oncology, Ljubljana, Slovenia
Treatment of Liver Metastases With Electrochemotherapy
Phase 1
Completed
- Conditions
- Liver Metastases
- First Posted Date
- 2010-12-22
- Last Posted Date
- 2020-11-24
- Lead Sponsor
- Institute of Oncology Ljubljana
- Target Recruit Count
- 16
- Registration Number
- NCT01264952
- Locations
- 🇸🇮
Institute of Oncology Ljubljana, Ljubljana, Slovenia
Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment
Phase 2
Completed
- Conditions
- Malignant Pleural Mesothelioma
- First Posted Date
- 2010-11-18
- Last Posted Date
- 2010-11-18
- Lead Sponsor
- Institute of Oncology Ljubljana
- Target Recruit Count
- 78
- Registration Number
- NCT01243632
- Locations
- 🇸🇮
Institute of Oncology Ljubljana, Ljubljana, Slovenia
Quality of Life in Patients After Combined Modality Treatment of Rectal Cancer
- Conditions
- Rectal Cancer
- Interventions
- Behavioral: questionnaires
- First Posted Date
- 2010-06-29
- Last Posted Date
- 2012-03-26
- Lead Sponsor
- Institute of Oncology Ljubljana
- Target Recruit Count
- 167
- Registration Number
- NCT01152164
- Locations
- 🇸🇮
Institute of Oncology, Ljubljana, Slovenia
Capecitabine as Radiosensitising Agent in Neoadjuvant Treatment of Locally Advanced Resectable Rectal Cancer
Phase 2
Completed
- Conditions
- Resectable Rectal Cancer Clinical Stage II and III
- First Posted Date
- 2010-06-29
- Last Posted Date
- 2010-06-29
- Lead Sponsor
- Institute of Oncology Ljubljana
- Target Recruit Count
- 57
- Registration Number
- NCT01152710
- Locations
- 🇸🇮
Institute of Oncology, Ljubljana, Slovenia
Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer
Phase 2
Completed
- Conditions
- Head and Neck Cancer
- Interventions
- First Posted Date
- 2009-03-25
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Institute of Oncology Ljubljana
- Target Recruit Count
- 30
- Registration Number
- NCT00868491
- Locations
- 🇸🇮
Institute of Oncology Ljubljana, Ljubljana, Slovenia
Preoperative Radiotherapy With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer: CRAB Phase II Study
Phase 2
- Conditions
- Locally Advanced Rectal Cancer
- First Posted Date
- 2009-02-12
- Last Posted Date
- 2012-03-26
- Lead Sponsor
- Institute of Oncology Ljubljana
- Target Recruit Count
- 60
- Registration Number
- NCT00842686
- Locations
- 🇸🇮
Onstitute of Oncology, Zaloška 2, Ljubljana, Slovenia
© Copyright 2025. All Rights Reserved by MedPath